 Alpna Tyagi
Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sirtuin 3 | 4 | 2023 | 58 | 2.130 |
Why?
| | Metabolic Syndrome | 4 | 2023 | 354 | 2.070 |
Why?
| | Grape Seed Extract | 6 | 2019 | 29 | 1.640 |
Why?
| | Antineoplastic Agents, Phytogenic | 7 | 2019 | 176 | 1.220 |
Why?
| | Alzheimer Disease | 4 | 2023 | 622 | 1.120 |
Why?
| | Silymarin | 13 | 2011 | 147 | 1.030 |
Why?
| | Anthocyanins | 2 | 2019 | 31 | 0.970 |
Why?
| | Apoptosis | 15 | 2019 | 2397 | 0.900 |
Why?
| | Neurodegenerative Diseases | 2 | 2025 | 150 | 0.840 |
Why?
| | Plaque, Amyloid | 2 | 2022 | 20 | 0.830 |
Why?
| | Amyloid | 3 | 2023 | 90 | 0.820 |
Why?
| | Insulysin | 1 | 2022 | 1 | 0.760 |
Why?
| | Anticarcinogenic Agents | 4 | 2013 | 61 | 0.690 |
Why?
| | Stilbenes | 4 | 2013 | 33 | 0.690 |
Why?
| | STAT3 Transcription Factor | 6 | 2013 | 205 | 0.640 |
Why?
| | Prostatic Neoplasms | 5 | 2019 | 978 | 0.640 |
Why?
| | Proanthocyanidins | 1 | 2019 | 6 | 0.590 |
Why?
| | Biflavonoids | 1 | 2019 | 6 | 0.590 |
Why?
| | Catechin | 1 | 2019 | 22 | 0.570 |
Why?
| | Urinary Bladder Neoplasms | 4 | 2013 | 260 | 0.530 |
Why?
| | Nitric Oxide Synthase Type II | 4 | 2011 | 161 | 0.520 |
Why?
| | Inflammasomes | 1 | 2018 | 145 | 0.510 |
Why?
| | Mitochondria | 3 | 2023 | 984 | 0.510 |
Why?
| | NF-kappa B | 5 | 2013 | 657 | 0.490 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 407 | 0.430 |
Why?
| | Receptors, Androgen | 1 | 2013 | 148 | 0.370 |
Why?
| | Carcinogens | 3 | 2013 | 123 | 0.370 |
Why?
| | Cyclooxygenase 2 | 2 | 2011 | 166 | 0.340 |
Why?
| | Down-Regulation | 6 | 2022 | 616 | 0.340 |
Why?
| | Lung Neoplasms | 5 | 2011 | 2660 | 0.340 |
Why?
| | Smad4 Protein | 1 | 2011 | 33 | 0.340 |
Why?
| | Cell Line, Tumor | 11 | 2013 | 3523 | 0.340 |
Why?
| | Reactive Oxygen Species | 2 | 2013 | 601 | 0.330 |
Why?
| | Brain | 3 | 2023 | 2933 | 0.320 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 106 | 0.310 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2013 | 643 | 0.310 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 135 | 0.290 |
Why?
| | Neovascularization, Pathologic | 3 | 2010 | 284 | 0.290 |
Why?
| | Mice | 14 | 2023 | 18261 | 0.280 |
Why?
| | Cell Proliferation | 9 | 2019 | 2489 | 0.280 |
Why?
| | DNA Damage | 1 | 2011 | 430 | 0.280 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 2007 | 5 | 0.270 |
Why?
| | Autocrine Communication | 1 | 2008 | 38 | 0.270 |
Why?
| | Interferon-gamma | 1 | 2011 | 781 | 0.270 |
Why?
| | Transforming Growth Factor alpha | 1 | 2008 | 55 | 0.270 |
Why?
| | Neoplasms, Hormone-Dependent | 1 | 2008 | 33 | 0.270 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2013 | 532 | 0.260 |
Why?
| | Cell Survival | 3 | 2019 | 1092 | 0.260 |
Why?
| | Interleukin-1beta | 2 | 2020 | 390 | 0.260 |
Why?
| | Angiogenesis Inhibitors | 1 | 2009 | 238 | 0.250 |
Why?
| | Caspase 2 | 1 | 2006 | 12 | 0.240 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2011 | 1207 | 0.240 |
Why?
| | cdc25 Phosphatases | 2 | 2006 | 13 | 0.240 |
Why?
| | CDC2 Protein Kinase | 2 | 2006 | 27 | 0.240 |
Why?
| | Head and Neck Neoplasms | 1 | 2011 | 562 | 0.240 |
Why?
| | S Phase | 1 | 2005 | 80 | 0.220 |
Why?
| | Fibronectins | 1 | 2025 | 132 | 0.220 |
Why?
| | Animals | 16 | 2025 | 37948 | 0.220 |
Why?
| | Tyrosine | 1 | 2005 | 219 | 0.210 |
Why?
| | ErbB Receptors | 1 | 2008 | 632 | 0.210 |
Why?
| | Cell Cycle | 4 | 2011 | 595 | 0.210 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 3 | 2011 | 171 | 0.210 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 881 | 0.190 |
Why?
| | Signal Transduction | 6 | 2011 | 5185 | 0.190 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2022 | 32 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2011 | 1437 | 0.180 |
Why?
| | Phosphorylation | 5 | 2013 | 1704 | 0.180 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2022 | 76 | 0.180 |
Why?
| | Adenocarcinoma | 1 | 2009 | 923 | 0.170 |
Why?
| | STAT1 Transcription Factor | 2 | 2011 | 66 | 0.170 |
Why?
| | Cell Movement | 2 | 2019 | 959 | 0.170 |
Why?
| | Caspase 9 | 2 | 2013 | 51 | 0.160 |
Why?
| | MAP Kinase Signaling System | 2 | 2013 | 306 | 0.160 |
Why?
| | Carcinoma | 3 | 2011 | 224 | 0.160 |
Why?
| | Amyloidosis | 1 | 2020 | 44 | 0.160 |
Why?
| | Cytochromes c | 2 | 2013 | 52 | 0.150 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 256 | 0.150 |
Why?
| | Immunoblotting | 2 | 2011 | 293 | 0.150 |
Why?
| | Antineoplastic Agents | 5 | 2013 | 2201 | 0.150 |
Why?
| | Caspase 3 | 2 | 2013 | 234 | 0.150 |
Why?
| | Jagged-1 Protein | 1 | 2019 | 22 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2005 | 589 | 0.140 |
Why?
| | Immunohistochemistry | 4 | 2011 | 1705 | 0.140 |
Why?
| | Male | 16 | 2020 | 72425 | 0.140 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.140 |
Why?
| | Receptor, Notch1 | 1 | 2019 | 63 | 0.140 |
Why?
| | Disease Models, Animal | 2 | 2020 | 4539 | 0.140 |
Why?
| | Mice, Nude | 5 | 2011 | 677 | 0.140 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 93 | 0.140 |
Why?
| | Spheroids, Cellular | 1 | 2019 | 74 | 0.140 |
Why?
| | Caspase 1 | 1 | 2018 | 146 | 0.140 |
Why?
| | Diet, Western | 1 | 2018 | 86 | 0.140 |
Why?
| | Prostate | 1 | 2019 | 158 | 0.130 |
Why?
| | Microglia | 1 | 2020 | 269 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 168 | 0.130 |
Why?
| | Xenograft Model Antitumor Assays | 5 | 2011 | 925 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2010 | 628 | 0.130 |
Why?
| | Oxidative Stress | 2 | 2013 | 1338 | 0.120 |
Why?
| | In Situ Nick-End Labeling | 3 | 2013 | 120 | 0.120 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 820 | 0.110 |
Why?
| | Fatty Acids | 1 | 2018 | 454 | 0.110 |
Why?
| | Humans | 19 | 2025 | 144665 | 0.100 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 9 | 0.100 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 25 | 0.100 |
Why?
| | Mice, Knockout | 2 | 2018 | 3109 | 0.100 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2013 | 14 | 0.100 |
Why?
| | Vitis | 1 | 2013 | 28 | 0.090 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2013 | 85 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 1186 | 0.090 |
Why?
| | Seeds | 1 | 2013 | 77 | 0.090 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2013 | 191 | 0.090 |
Why?
| | Comet Assay | 1 | 2011 | 14 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1241 | 0.090 |
Why?
| | Colorectal Neoplasms | 2 | 2010 | 849 | 0.090 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2011 | 55 | 0.090 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2011 | 70 | 0.080 |
Why?
| | Microtubule-Associated Proteins | 2 | 2013 | 195 | 0.080 |
Why?
| | Cyclin D1 | 2 | 2008 | 63 | 0.080 |
Why?
| | BRCA1 Protein | 1 | 2011 | 82 | 0.080 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 130 | 0.080 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 93 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 835 | 0.080 |
Why?
| | Antioxidants | 2 | 2010 | 546 | 0.070 |
Why?
| | Checkpoint Kinase 2 | 2 | 2006 | 27 | 0.070 |
Why?
| | Transfection | 1 | 2011 | 924 | 0.070 |
Why?
| | Azoxymethane | 1 | 2008 | 18 | 0.070 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2006 | 68 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 14 | 0.070 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2008 | 17 | 0.070 |
Why?
| | beta Catenin | 1 | 2010 | 252 | 0.070 |
Why?
| | Up-Regulation | 1 | 2011 | 848 | 0.070 |
Why?
| | Mice, Inbred ICR | 1 | 2007 | 113 | 0.070 |
Why?
| | Microvessels | 1 | 2009 | 98 | 0.070 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2008 | 69 | 0.060 |
Why?
| | Blotting, Western | 4 | 2011 | 1161 | 0.060 |
Why?
| | Gallic Acid | 1 | 2006 | 9 | 0.060 |
Why?
| | Precancerous Conditions | 1 | 2008 | 166 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2008 | 2019 | 0.060 |
Why?
| | Toluene | 1 | 2006 | 12 | 0.060 |
Why?
| | Tumor Suppressor Proteins | 2 | 2006 | 319 | 0.060 |
Why?
| | Androgens | 1 | 2008 | 178 | 0.060 |
Why?
| | Benzothiazoles | 1 | 2006 | 39 | 0.060 |
Why?
| | Histones | 1 | 2011 | 663 | 0.060 |
Why?
| | Ataxia Telangiectasia | 1 | 2005 | 18 | 0.060 |
Why?
| | Checkpoint Kinase 1 | 1 | 2005 | 27 | 0.060 |
Why?
| | Ribonucleotide Reductases | 1 | 2005 | 29 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2011 | 1106 | 0.060 |
Why?
| | Neurofibrillary Tangles | 1 | 2023 | 13 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2011 | 4110 | 0.050 |
Why?
| | Protein Kinases | 1 | 2005 | 314 | 0.050 |
Why?
| | Multigene Family | 1 | 2023 | 210 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2008 | 675 | 0.050 |
Why?
| | Enzyme Activation | 3 | 2011 | 762 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2006 | 1484 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 243 | 0.040 |
Why?
| | Macrophages | 1 | 2009 | 1496 | 0.040 |
Why?
| | Cytokines | 1 | 2009 | 2045 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4081 | 0.040 |
Why?
| | Cell Death | 2 | 2013 | 382 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2008 | 2815 | 0.040 |
Why?
| | Janus Kinase 1 | 2 | 2011 | 26 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1811 | 0.030 |
Why?
| | Female | 3 | 2020 | 78301 | 0.030 |
Why?
| | Time Factors | 1 | 2008 | 7140 | 0.030 |
Why?
| | Exercise | 1 | 2025 | 2183 | 0.020 |
Why?
| | Tongue | 1 | 2013 | 77 | 0.020 |
Why?
| | Cell Cycle Checkpoints | 1 | 2013 | 98 | 0.020 |
Why?
| | Superoxides | 1 | 2013 | 199 | 0.020 |
Why?
| | Cytoplasm | 1 | 2013 | 257 | 0.020 |
Why?
| | Carcinogenesis | 1 | 2013 | 227 | 0.020 |
Why?
| | HT29 Cells | 1 | 2011 | 37 | 0.020 |
Why?
| | Nestin | 1 | 2010 | 19 | 0.020 |
Why?
| | Intermediate Filament Proteins | 1 | 2010 | 57 | 0.020 |
Why?
| | Urethane | 1 | 2010 | 43 | 0.020 |
Why?
| | Autophagy | 1 | 2013 | 284 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 86 | 0.020 |
Why?
| | X-Ray Microtomography | 1 | 2010 | 107 | 0.020 |
Why?
| | Genes, APC | 1 | 2010 | 11 | 0.020 |
Why?
| | HCT116 Cells | 1 | 2010 | 78 | 0.020 |
Why?
| | DNA Primers | 1 | 2011 | 507 | 0.020 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2010 | 50 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 324 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 364 | 0.020 |
Why?
| | Wnt Proteins | 1 | 2010 | 133 | 0.020 |
Why?
| | Gene Deletion | 1 | 2010 | 392 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2010 | 317 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 48 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2010 | 376 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2008 | 268 | 0.020 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2008 | 45 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 195 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1047 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2177 | 0.020 |
Why?
| | Janus Kinase 2 | 1 | 2007 | 29 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2011 | 1078 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 590 | 0.020 |
Why?
| | Cyclins | 1 | 2006 | 79 | 0.020 |
Why?
| | Caspases | 1 | 2006 | 229 | 0.010 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2006 | 122 | 0.010 |
Why?
| | Administration, Oral | 1 | 2008 | 851 | 0.010 |
Why?
| | Repressor Proteins | 1 | 2008 | 428 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2013 | 5967 | 0.010 |
Why?
| | Rats | 1 | 2008 | 5570 | 0.010 |
Why?
| | Lung | 1 | 2010 | 4089 | 0.010 |
Why?
|
|
Tyagi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|